The potential growth difference for the antacids market between 2021 and 2026 is USD 712.45 million, as per the latest market analysis report by Technavio. The report also identifies the market to witness an accelerating CAGR of 3.37%.
To get the exact yearly growth variance and the Y-O-Y growth rate, Talk to our analyst.
Key Market Dynamics:
- Market Driver: Rising geriatric population is one of the key factors anticipated to drive the market growth. With age, the sphincter in the lower esophagus tends to relax, which allows acid to reflux or flow backward, causing heartburn. Heartburn can also be caused by GERD. Age is directly related to the increase in various disorders, including GERD. Furthermore, advances in healthcare and advanced treatment options for various diseases have increased the average life expectancy of people.
- Market Challenge: One of the key challenges to the global antacids market growth is the adverse effect of prolonged use of antacids. Many antacids such as Maalox, Mylanta, Rolaids, and TUMS contain calcium. If these are taken in high doses, patients could be at risk of calcium overdose, which can lead to adverse effects such as nausea, kidney stones, and swelling of the feet. The availability of OTC antacids and their combined use with other medications can result in drug-drug interactions and have serious side effects.
To learn about additional key drivers, trends, and challenges available with Technavio, Read our FREE Sample Report!
Key Market Segment Analysis:
The antacids market report is segmented by Type (Non-symmetric antacids and Symmetric antacids) and Geography (North America, Europe, Asia, and Rest of World (ROW)).
- The non-systemic antacids segment is expected to grow at a moderate rate in the coming years owing to better efficacy demonstrated when used in combination. In addition, the drugs used as combination therapies minimize the adverse effects and effectively treat GERD and acid reflux.
- North America will be the leading region with 41% of the market's growth during the forecast period. US and Canada are the key markets for antacids in North America. The high prevalence of GERD for which antacids are predominantly used, the increasing preference for OTC medications, and the practice of self-medication among the population will facilitate the antacids market growth in North America over the forecast period.
View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.
Some Companies Mentioned
- Advance Pharmaceutical Inc.
- AmerisourceBergen Corp.
- Bayer AG
- Cardinal Health Inc.
- GlaxoSmithKline Plc
- Humco Holding Group Inc.
- iNova Pharmaceuticals
- Johnson and Johnson
- Neogen Corp.
- Novartis AG
- NuCare Laboratories India
- Pfizer Inc.
- Pharmaceutical Associates Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- United Natural Foods Inc.
- WellSpring Pharmaceutical Corp.
- The Procter and Gamble Co.
- To gain access to more vendor profiles with their key offerings available with Technavio, Click Here
Related Reports:
Atherosclerosis Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026
Thrombosis Drugs Market by Indication and Geography - Forecast and Analysis 2022-2026
Antacids Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.37% |
Market growth 2022-2026 |
$ 712.45 million |
Market structure |
Fragmented |
YoY growth (%) |
3.11 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key consumer countries |
US, Canada, Brazil, Germany, and UK |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Key Topics Covered:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Non-symmetric antacids - Market size and forecast 2021-2026
- Exhibit 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
- 5.4 Symmetric antacids - Market size and forecast 2021-2026
- Exhibit 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 Canada - Market size and forecast 2021-2026
- Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 Brazil - Market size and forecast 2021-2026
- Exhibit 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 AmerisourceBergen Corp.
- Exhibit 85: AmerisourceBergen Corp. - Overview
- Exhibit 86: AmerisourceBergen Corp. - Business segments
- Exhibit 87: AmerisourceBergen Corp. - Key offerings
- Exhibit 88: AmerisourceBergen Corp. - Segment focus
- 10.4 Bayer AG
- Exhibit 89: Bayer AG - Overview
- Exhibit 90: Bayer AG - Business segments
- Exhibit 91: Bayer AG - Key offerings
- Exhibit 92: Bayer AG - Segment focus
- 10.5 Cardinal Health Inc.
- Exhibit 93: Cardinal Health Inc. - Overview
- Exhibit 94: Cardinal Health Inc. - Business segments
- Exhibit 95: Cardinal Health Inc. - Key news
- Exhibit 96: Cardinal Health Inc. - Key offerings
- Exhibit 97: Cardinal Health Inc. - Segment focus
- 10.6 GlaxoSmithKline Plc
- Exhibit 98: GlaxoSmithKline Plc - Overview
- Exhibit 99: GlaxoSmithKline Plc - Business segments
- Exhibit 100: GlaxoSmithKline Plc - Key news
- Exhibit 101: GlaxoSmithKline Plc - Key offerings
- Exhibit 102: GlaxoSmithKline Plc - Segment focus
- 10.7 Humco Holding Group Inc.
- Exhibit 103: Humco Holding Group Inc. - Overview
- Exhibit 104: Humco Holding Group Inc. - Product / Service
- Exhibit 105: Humco Holding Group Inc. - Key offerings
- 10.8 Johnson and Johnson
- Exhibit 106: Johnson and Johnson - Overview
- Exhibit 107: Johnson and Johnson - Business segments
- Exhibit 108: Johnson and Johnson - Key news
- Exhibit 109: Johnson and Johnson - Key offerings
- Exhibit 110: Johnson and Johnson - Segment focus
- 10.9 Novartis AG
- Exhibit 111: Novartis AG - Overview
- Exhibit 112: Novartis AG - Business segments
- Exhibit 113: Novartis AG - Key offerings
- Exhibit 114: Novartis AG - Segment focus
- 10.10 Sanofi SA
- Exhibit 115: Sanofi SA - Overview
- Exhibit 116: Sanofi SA - Business segments
- Exhibit 117: Sanofi SA - Key news
- Exhibit 118: Sanofi SA - Key offerings
- Exhibit 119: Sanofi SA - Segment focus
- 10.11 Sun Pharmaceutical Industries Ltd.
- Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings
- 10.12 WellSpring Pharmaceutical Corp.
- Exhibit 123: WellSpring Pharmaceutical Corp. - Overview
- Exhibit 124: WellSpring Pharmaceutical Corp. - Product / Service
- Exhibit 125: WellSpring Pharmaceutical Corp. - Key offerings
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 126: Inclusions checklist
- Exhibit 127: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 128: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 129: Research methodology
- Exhibit 130: Validation techniques employed for market sizing
- Exhibit 131: Information sources
- 11.5 List of abbreviations
- Exhibit 132: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article